Medicine/Healing

Pharmaceuticals and brain health… biotech industry?

McDonald explains, “We are improving on first-generation psychedelic compounds like psilocybin. Unlike other products on the market, we are developing next-generation superior molecules that are engineered to target specific serotonin receptors. Our drugs will replace psilocybin in dealing with issues like depression. This leads to fewer side effects while improving safety and efficacy.” 

Biotech companies can sometimes find the development of new products and drugs difficult, with various hurdles and lengthy trials slowing progress. However, due to advances already made and the urgency of the demand… psychedelic neuroscience companies [apparently] face less risk and can bring out products faster than others in the pharmaceutical field.

Original Article (International Business Times):
Pharmaceuticals and brain health: what’s the next step for the biotech industry?
Artwork Fair Use: Canadian Film Centre from Toronto, Canada

Spirituality

LSD… benefits…

Psychology

…salvinorin…

Anthropology

There will be oil

Anthropology

Cannabis goes green

Psychology

Home grow…

Psychology

…for macrodosing

Politics

First, it was weed…

Politics

Manufacturing…

Spirituality

…the Mushroom

Politics

Oregon psilocybin…

Science

What is kratom…?

Politics

SITSA … stopped

Politics

Grassy Globes

Politics

Weed wages water war

Politics

Big acid

Politics

Can Kratom be patented?

Science

Kratom LD-50 Stats

Science

Rolling in the deep

Science

The Peace Drug